Automate Your Wheel Strategy on UNH
With Tiblio's Option Bot, you can configure your own wheel strategy including UNH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNH
- Rev/Share 462.8297
- Book/Share 339.0912
- PB 0.0
- Debt/Equity 0.0
- CurrentRatio 0.8458
- ROIC 0.1313
- MktCap 226385858400.0
- FreeCF/Share 27.7703
- PFCF 8.9583
- PE 10.664
- Debt/Assets 0.0185
- DivYield 0.0341
- ROE 0.3018
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | UNH | Robert W. Baird | Neutral | Underperform | -- | $198 | July 31, 2025 |
| Reiterated | UNH | Oppenheimer | -- | Outperform | $400 | $325 | July 30, 2025 |
| Downgrade | UNH | Robert W. Baird | Outperform | Neutral | -- | $312 | June 11, 2025 |
| Downgrade | UNH | HSBC Securities | Hold | Reduce | -- | $270 | May 21, 2025 |
| Downgrade | UNH | TD Cowen | Buy | Hold | -- | $308 | May 19, 2025 |
| Downgrade | UNH | Raymond James | Strong Buy | Market Perform | -- | -- | May 14, 2025 |
| Downgrade | UNH | BofA Securities | Buy | Neutral | -- | $350 | May 14, 2025 |
| Downgrade | UNH | HSBC Securities | Buy | Hold | -- | $490 | April 22, 2025 |
| Downgrade | UNH | Argus | Buy | Hold | -- | -- | April 21, 2025 |
| Upgrade | UNH | HSBC Securities | Hold | Buy | -- | $595 | Jan. 10, 2025 |
News
Options Corner: UNH Steep Decline
Published: August 01, 2025 by: Schwab Network
Sentiment: Negative
UnitedHealth (UNH) shares have plummeted to the downside in a strong downtrend thus far in 2025. Tom White looks at the healthcare company and discusses its weight on the Dow Jones Industrial Avg.
Read More
UnitedHealth: The Disappointment Continues
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Negative
UnitedHealth Group Incorporated faces ongoing structural headwinds, poor execution, and a dramatic EPS reset, making a quick recovery highly unlikely. Management's guidance lacks confidence, with 2025 adjusted EPS slashed to $16, down substantially from its original outlook. While management has postured for further improvements through 2027, investors aren't buying into UNH's optimism yet.
Read More
Dow Jones: Microsoft Tops $4T Market Cap, But UnitedHealth Drop Pressures Index
Published: July 31, 2025 by: FXEmpire
Sentiment: Neutral
Dow slips as UnitedHealth weighs, while Microsoft hits $4T value and fuels Nasdaq gains. Traders eye Apple and Amazon earnings later today.
Read More
UnitedHealth Q2: Seeing More Clarity Could Be Positive For The Stock
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Neutral
UNH's Q2 FY2025 results significantly missed EPS expectations due to higher medical costs, and its updated FY2025 guidance came in largely below consensus. Higher MA cost trends continue to pressure margins in 2H 2025, and management now expects 2026 costs to rise further after miscalculation. Adjusted EPS is expected to decline 66% YoY in 2H FY2025, with FY2025 guidance at least $16 per share, implying a 42% YoY drop.
Read More
UnitedHealth: The Bottom Might Be In (Technical Analysis)
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Despite rising medical costs and margin pressures, UnitedHealth Group Incorporated remains solidly profitable, with strong sales growth and a robust net earnings base. UNH stock is now technically oversold, trading at just 12x 2026 estimated profits and offering a 3.3% dividend yield, making it attractive for value investors. A recovery is possible if UnitedHealth Group controls its medical care ratio and meets profit guidance, with even slight improvements likely to shift sentiment positively.
Read More
Trade Tracker: Steve Weiss sells UnitedHealth and buys more FTAI Aviation
Published: July 30, 2025 by: CNBC Television
Sentiment: Neutral
Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC's “Halftime Report” to detail his latest portfolio moves.
Read More
Here's the best time to buy UnitedHealth (UNH) stock, according to AI
Published: July 30, 2025 by: Finbold
Sentiment: Neutral
UnitedHealth's (NYSE: UNH) turbulent run in 2025 is escalating after the firm reported disappointing Q2 earnings results, but an AI platform has identified strategic entry points for long-term investors.
Read More
UnitedHealth Faces Long Road to Recovery
Published: July 30, 2025 by: WSJ
Sentiment: Negative
Returning CEO Stephen Hemsley is lowering expectations, but perhaps not enough.
Read More
UnitedHealth: Why This Healthcare Giant May Keep Sinking For The Rest Of The Year
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Negative
My bearish thesis on UnitedHealth Group Incorporated is playing out, with margins and earnings deteriorating as expected after Q2 FY25 results. The onus is on management to prove this is the bottom. Management's disappointing FY25 revenue guidance adds to challenges, making a turnaround story unlikely in the near term. Valuations may appear reasonable and even low depending on how you look at it, but I believe eroding earnings fundamentals make this a "no-go" for buys.
Read More
UnitedHealth Stock Is A Strong Buy Amid Unfavorable Medical Trends (Upgrade)
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Positive
Despite a double earnings miss, I am upgrading UnitedHealth Group Incorporated stock to Strong Buy due to its long-term growth potential and resilient fundamentals. UNH's current valuation prices in excessive pessimism; I believe earnings will recover as premium repricing and cost controls take effect. Management's transparency, share repurchases, and a growing dividend support my conviction in UNH's ability to outperform the S&P 500 over time.
Read More
UnitedHealth Group Incorporated (UNH) Q2 2025 Earnings Call Transcript
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group Incorporated (NYSE:UNH ) Q2 2025 Earnings Conference Call July 29, 2025 8:45 AM ET Company Participants Bobby Hunter - CEO of Government Programs & Head of Medicare Insurance - Corporate Participant Daniel J. Schumacher - President Daniel Roger Kueter - Chief Executive Officer of UnitedHealthcare Employer & Individual - Corporate Participant Dhivya Suryadevara - Chief Executive Officer of Optum Financial Services - Corporate Participant Krista Nelson - Chief Executive Officer of UnitedHealthcare Community & State - Corporate Participant Timothy John Noel - Chief Executive Officer of UnitedHealthcare Business John F.
Read More
'Halftime' Committee Stocks on the Move: UnitedHealth, Merck, Royal Caribbean and Spotify
Published: July 29, 2025 by: CNBC Television
Sentiment: Negative
The Investment Committee debate some of their stocks on the move lower.
Read More
UnitedHealth Q2 Earnings Review: Still On The Canvas, While America Watches On
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Negative
UnitedHealth Group Incorporated's Q2 results show revenue growth but sharply lower earnings, with margins under pressure from higher medical costs and Medicare Advantage miscalculations. Management reinstated 2025 guidance but cut EPS forecasts in half, warning that recovery will be slow and margins will remain compressed for several years. Both UnitedHealthcare and Optum face significant headwinds, including regulatory risk, rising costs, and underperformance in value-based care and PBM businesses.
Read More
UnitedHealth: Buy This Generational Wealth Compounder While It's On Sale
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth's stock decline is overdone; DOJ investigation risk is likely manageable, with historical precedent suggesting a fine and agreement as the worst-case outcome. Medicaid margin pressures are temporary, with pricing power expected to return in 2026, restoring profitability for UnitedHealth and peers. Insider buying and a strong management track record reinforce my conviction in UnitedHealth's long-term compounding potential and resilience.
Read More
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Negative
UNH misses Q2 earnings estimates as surging medical costs slash EPS 40%, despite revenue growth and Optum Rx strength.
Read More
UnitedHealth Group stock price drops again as the health insurance giant's sickly summer continues
Published: July 29, 2025 by: Fast Company
Sentiment: Negative
UnitedHealthcare's parent company, UnitedHealth Group, is in need of some bed rest this week. The company's stock price (NYSE: UNH) has been knocked off its feet again after the American insurance giant reported disappointing quarterly results and offered 2025 earnings guidance that was significantly below investor expectations.
Read More
UnitedHealth, UPS, and Whirlpool Show First Cracks in a Strong Earnings Season
Published: July 29, 2025 by: Barrons
Sentiment: Negative
Tech and financials are booming. Other sectors are struggling.
Read More
2 Blue-Chip Stocks Making Moves After Earnings
Published: July 29, 2025 by: Schaeffers Research
Sentiment: Positive
Aerospace giant Boeing Co (BA) reported impressive second-quarter results before the bell this morning, including narrower-than-expected losses of $1.24 per share on a revenue beat of $22.75 billion.
Read More
UNH Continues 50% Y/Y Slide, SPOT Sells Off, WHR "Tariff Exposed Story"
Published: July 29, 2025 by: Schwab Network
Sentiment: Negative
It's all down arrows on this morning's earnings movers. Sam Vadas talks about the "tariff exposed story" impacting Whirlpool (WHR) and UPS Inc. (UPS).
Read More
Here's What Key Metrics Tell Us About UnitedHealth (UNH) Q2 Earnings
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
UnitedHealth misses profit estimates, reinstates outlook below expectations
Published: July 29, 2025 by: Proactive Investors
Sentiment: Negative
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) reported second-quarter earnings that fell short of Wall Street expectations and reinstated a full-year forecast well below consensus. The company posted adjusted earnings of $4.08 per share for the quarter ended June 30, significantly below analysts' estimates of $4.45, and marking a 14% decline from a year earlier.
Read More
UnitedHealth: Everything You Need To Know
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Positive
Q2 was challenging. Management can address profitability by repricing, optimizing care strategies, and adjusting for higher member usage, though a turnaround will take several quarters. Despite regulatory scrutiny and operational challenges, the business remains profitable.
Read More
Mizuho's Jared Holtz: UnitedHealth's trough earnings number is what we're all trying to see
Published: July 28, 2025 by: CNBC Television
Sentiment: Neutral
Jared Holtz, Mizuho health care sector strategist, joins 'Power Lunch' to discuss what investors should do with stocks in the health care sector, the tariff angle to big pharma and much more.
Read More
Can Optum Support UnitedHealth's Profit Amid Industry Headwinds?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Negative
UNH leans on Optum's diversified growth and value-based care to counter insurance sector margin pressure in Q2.
Read More
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
UnitedHealthcare Pressure Builds: Trouble Ahead for UNH's Q2 Earnings?
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
UNH braces for a steep Q2 profit drop as soaring medical costs and DOJ scrutiny shake investor confidence.
Read More
UnitedHealth's stock doesn't offer much value, says Raymond James' John Ransom
Published: July 24, 2025 by: CNBC Television
Sentiment: Negative
Jeff Jonas, Gabelli portfolio manager, and John Ransom, Raymond James director of healthcare research, join 'Power Lunch' to discuss each expert's thoughts on UnitedHealth amid its recent plunge.
Read More
UnitedHeath shares fall after health-care giant admits DOJ fraud probe into Medicare business
Published: July 24, 2025 by: New York Post
Sentiment: Negative
Company shares have tumbled since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan.
Read More
UnitedHealth on Thin Ice Before Q2 Earnings: Should Investors Exit?
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
UNH braces for a 27% earnings drop in Q2 as soaring medical costs, margin pressure and investor jitters weigh on performance.
Read More
Pre-Markets Mixed Despite Strong Earnings Results
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Pre-Markets Mixed Despite Strong Earnings Results.
Read More
About UnitedHealth Group Incorporated (UNH)
- IPO Date 1984-10-17
- Website https://www.unitedhealthgroup.com
- Industry Medical - Healthcare Plans
- CEO Stephen J. Hemsley
- Employees 400000